Volga | Technology & innovation | Retail, FMCG

Digital passport ensures pharma products’ authenticity

18 Jun '20
Two Russian companies, ANO Airalab Rus and Innocolloid, Inc., have teamed up in their joint R&D project aimed at creating what they refer to as “digital passport” for their new anti-viral blocker called Blokator.

The word came from the website of Zhigulevskaya Dolina, a large technopark and business incubator in Samara Oblast, in Russia’s Lower Volga region, which hosts ANO Airalab Rus as one of its numerous resident companies. Airalab’s partner in the effort, Innocolloid, is the co-founder of ITMO, one of the newest and most innovative universities in St. Petersburg.

The Blokator reportedly demonstrates disinfectant properties and is designed to thwart viral and microbial activity. Tests are said to have proved its efficacy in inhibiting human respiratory viruses—but the solution is not a drug in a strict therapeutic sense of the word. The Russian solution is meant to compete with Japanese anti-viral blockers that currently dominate the blockers market.

Ivan Petrov, ANO Airalab Rus’ Executive Director, explained why a digital passport is a must for solutions like this one:

“With a digital passport, a maximum possible level of trust can be established between all those involved in product development, including suppliers, manufacturers, vendors and service chains—not only between a buyer and an actual seller. Our proprietary R&D results, platform and blockchain technology ensure a maximum possible level of data protection.”

Alexander Vinogradov, the head of ITMO University’s Chemistry and Biology Cluster:

“The consumer is in need of protective means, given the current outbreak of a viral infection. But there’s an obvious deficit of imported blockers in the market today! That’s why the new domestic development is perfectly timed.”

Mr. Vinogradov said that his company expected various forged imitations of the Blokator to infiltrate the market; therefore, the partners have decided to suspend the manufacture of the blocker until the above digital passport by Airalab is fully in place. The innovation is expected to prevent fakes from unsettling the market and ruining the customers’ trust.

The pharmaceutical industry is but one sector to benefit from ANO Airalab Rus’ tech solutions. The company has already introduced similar solutions to customers in the environmental protection projects, in heavy industry, and in the food sector.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content

Locations: Samarskaya oblast

Tags: ITMO University (5) / Zhigulevskaya Dolina (2) / human respiratory viruses (0) / digital passport (0) / Innocolloid (0) / Blokator (0) / ANO Airalab Rus (0) /

Latest News: Volga
30 Jun '20 | Technology & innovation
18 Jun '20 | Technology & innovation
18 Jun '20 | Technology & innovation | Retail, FMCG
16 Jun '20 | Technology & innovation

Feature stories

21 May '20
Russian and Italian researchers have developed a...
5 Apr '20
To extend the service life of medical fabric masks—an...
26 Feb '20
A Russian developer has come up with its own...
Search (News archive - 22071)

World of the Future, World of AI

Luc Jones: A Guide to Doing Business in Russia and the CIS Countries
Why Russians Don't Smile
Marchmont News

Latest News

3 Jul '20
A California-based start-up of Russian origin raised...
2 Jul '20
A Covid-19 vaccine has been unofficially tested on...
30 Jun '20
A Russian Linux-based operating system has been...

Most read stories from last week

3 Jul '20
Russian biophysicists have created a compact device...
3 Jul '20
Piezus LLC, a resident of the Technopolis Moscow SEZ,...
3 Jul '20
A California-based start-up of Russian origin raised...